...
首页> 外文期刊>Trials >Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial
【24h】

Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial

机译:针刺治疗对无痴呆的血管性认知障碍的影响:一项随机对照试验的研究方案

获取原文
           

摘要

Background Vascular cognitive impairment, no dementia (VCIND) is a condition at risk for future dementia and should be the target of preventive strategies. Preliminary evidence suggests that acupuncture may be a clinically effective intervention for people with early-stage vascular cognitive impairment. We will do a multicenter, 6-month, drug-controlled, nonblinded, randomized, parallel-group trial to determine whether acupuncture is effective for improving cognitive function and quality of life for patients with VCIND. Methods/Design A total of 216 eligible patients will be recruited and randomly assigned acupuncture for two sessions/week (n =?108) or citicoline 300 mg/day (n =?108) in a multicenter, 6-month trial. The primary endpoint is cognition (Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-cog)). Secondary endpoints include assessments of activities of daily living and behavioral symptoms (Clock Drawing Test (CDT), Activities of Daily Living (ADL) and Instrumental Activities of Daily Living scale (IADL)). Discussion This will be the first large-scale trial specifically evaluating acupuncture therapy in VCIND. If the study confirms the effectiveness and safety of acupuncture treatment, it will be important to examine how the acupuncture approach could most effectively be integrated into the provision of routine healthcare. Trial registration This study is registered as an International Standard Randomised Controlled Trial on 17 January 2014, number ISRCTN 82980206
机译:背景血管性认知功能障碍,无痴呆症(VCIND)是将来发生痴呆症的风险,应作为预防策略的目标。初步证据表明,针灸可能是早期血管性认知障碍患者的临床有效干预措施。我们将进行一项多中心,为期6个月,药物控制,无盲,随机,平行分组的试验,以确定针灸是否有效改善VCIND患者的认知功能和生活质量。方法/设计在多中心,为期6个月的试验中,将总共招募216名合格患者,并随机分配针灸,每周两次,每周一次(n = 108),或胞磷胆碱300 mg /天(n = 108)。主要终点是认知(阿尔茨海默氏病评估量表,认知子量表(ADAS-cog))。次要终点包括对日常生活活动和行为症状的评估(钟表测试(CDT),日常生活活动(ADL)和日常生活工具活动量表(IADL))。讨论这将是第一个专门评估VCIND针灸疗法的大规模试验。如果研究证实了针灸治疗的有效性和安全性,那么重要的是研究如何将针灸方法最有效地整合到常规医疗保健中。试验注册该研究于2014年1月17日注册为国际标准随机对照试验,编号ISRCTN 82980206

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号